Search

You searched for "inflammation"

2030 results found

Risk factors and untreated POAG

1 December 2013 | | EYE - Glaucoma
The authors examined 50 untreated open angle glaucoma patients to determine if there was an association between the level of glaucomatous damage and documented risk factors. In this study the authors measured the extent of morphologic and functional glaucomatous damage...

Effect of refractive corneal surgery on IOP and glaucoma progression

1 December 2018 | | EYE - Glaucoma
Accuracy of intraocular pressure (IOP) measurement depends on the biomechanical properties of the cornea, including its thickness central corneal thickness (CCT) and keratometry (K). Fifty-six eyes of 56 patients with primary open angle glaucoma (POAG) who had a history of...

Effect of phacoemulsification on facility of outflow

1 February 2019 | | EYE - Glaucoma
This is a prospective study to examine the change in electronic Schotz tonographic outflow (TOF) and IOP measurements after phacoemulsification. Intraocular pressure was measured using Goldman‘s applanation tonography (GAT). Data were collected at baseline, three, six and 12 months postoperatively....

COVID-19 and the eye: a review of ocular involvement and protective strategies

1 June 2020 | | EYE - General
A lot of attention has been placed on the use of face coverings to limit COVID-19 transmission, but there has been less focus on ocular involvement and ocular protection strategies. The author reviews the literature and discusses possible solutions. The...

What's trending Aug/Sep 2024

2 August 2024 | | EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #GeneralElection #RightToVote It goes without saying that the general election has been dominating the headlines and with it, the challenges many...

Quality matters in the management of serious eye disorders

1 June 2019 | | EYE - Cataract, EYE - Glaucoma, EYE - Neuro-ophthalmology, EYE - Vitreo-Retinal
The author discusses the first quality standard for serious eye disorders from NICE and takes a look at new care models for enhanced service delivery. Patient backlogs pose risks to patient safety, with research showing that people are losing sight...

The Sickle Cell Retinopathy Network is leading global change in screening and management

2 October 2025 | | EYE - Vitreo-Retinal
Sickle cell disease or disorder (SCD) is one of the most neglected health conditions in the world. A strong hypothesis is that this is because SCD affects people of African, Caribbean and other Global Majority communities and has received disproportionately...

My Top Five: Emerging technologies revolutionising ophthalmology

3 October 2024 | | EYE - Vitreo-Retinal, EYE - Cataract, EYE - Refractive, EYE - Cornea
Advancements in ophthalmology have significantly transformed eyecare practices. This article explores five emerging technologies that are revolutionising the field, from virtual reality (VR) surgical training to novel therapies for corneal conditions. These innovations are reshaping how eyecare professionals diagnose, treat...

HS-UK ‘Improving Outcomes’ Clinical Decisions & Management Course

20 June 2025
The ‘Improving Outcomes’ Biometry: Clinical Decisions & Management course focuses on how biometry measurements can be used to guide clinical decision making. This includes evidence-based approaches to selecting the appropriate formulae, planning for more complex cataract cases, and approaches to...

Preparing to start as a consultant

5 December 2025 | | EYE - Cataract, EYE - Glaucoma
I was just coming to the end of a fantastic glaucoma fellowship at Moorfields, during which Samad Ansari had been a colleague and friend, and soon to start as a consultant in Oxford where Rebecca Turner is Clinical Director, and...

RNIB and Abertay University hold event to reboot gaming to make it more accessible for those with sight loss

3 October 2022
Sight loss charity Royal National Institute of Blind People (RNIB) and Abertay University in Dundee will host a pioneering Accessible Gaming Symposium this week.

Recurrent corneal erosions secondary to isotretinoin use

7 December 2020 | | EYE - Cornea, EYE - Glaucoma
Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations, as shown in Table 1 [3]. These side-effects need...